Related Experiment Video
Updated: Apr 17, 2026

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
Published on: June 29, 2019
Reduction of inappropriate exit prescriptions for proton pump inhibitors: A before-after study using education paired
Emily G McDonald1, Janelle Jones, Laurence Green
1Division of General Internal Medicine, Department of Medicine, McGill University Health Centre, Montreal, Canada; McGill Centre for Quality Improvement, Montreal, Canada.
Background:
Proton pump inhibitors (PPIs) are overprescribed despite concerns regarding associated adverse drug events.
Objective:
To reduce inappropriate PPI prescriptions using hospitalization as the point of contact to effect meaningful change.
Design:
Before-after study design.
Setting:
Forty-six-bed medical clinical teaching unit in a 417-bed university teaching hospital in Montreal, Canada.
Patients:
Four hundred sixty-four consecutively admitted patients in the preintervention control group, and 640 consecutively admitted patients in the intervention group.
Intervention:
A monthly educational intervention paired with a Web-based quality improvement tool.
Measurements:
We determined the proportion of patients admitted on PPIs, their indications, and appropriateness of use. We then compared the proportion of patients whose PPIs were discontinued at discharge before and after our intervention.
Results:
Forty-four percent of patients were already using a PPI prior to their hospitalization. In evaluated patients, only 54% of these patients had an evidence-based indication for ongoing use. The proportion of PPIs discontinued at hospital discharge increased from 7.7% per month in the 6 months prior to intervention, to 18.5% per month postintervention (P = 0.03).
Conclusions:
Strategies to combat PPI overuse are needed to improve the overall quality of patient care. We significantly reduced discharge prescriptions for PPIs through the implementation of an educational initiative paired with a Web-based quality improvement tool. An active interventional strategy is likely required considering the increasingly recognized and preventable adverse events associated with PPI misuse.
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Pharmaceutical Poisoning: Potential Scenarios
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

